Redefining the Future of Cancer Treatment

 

ProNova SC360 Proton Therapy System | The Next Generation of Proton Therapy

 

ProNova delivers a lower-cost, smaller, lighter and more energy efficient proton therapy solution without sacrificing today’s most important clinical capabilities. With more than 1.7 million people to be diagnosed with cancer this year, 340,000 of whom will be potential candidates for proton therapy, a low-cost treatment option is needed. Introducing the ProNova SC360, a no-compromise proton therapy solution that will make proton therapy more accessible to patients and physicians.

The SC360 is the only compact proton therapy system that maintains a full 360˚ treatment angle.

50
Cost Effective

Up to 50% lower construction costs

81
Energy Efficient

Up to 81% less power consumed with superconducting magnets

83
Smaller & Lighter

Up to 52% smaller and 83% lighter than other systems

360
No Compromises

Full 360˚ Gantry improving productivity
Fast scanning IMPT
Most advanced IGRT available

Bringing Innovative Cancer Treatment to Patients with a History of Success

ProNova has assembled a strong technical and commercial team of experienced and knowledgeable entrepreneurs who have demonstrated success in the development and delivery of advanced technology to the medical device market. Founded by the leaders of CTI Molecular Imaging, ProNova’s team brought positron emission tomography (PET) technology out of the laboratory and made it a clinical reality for millions of cancer patients. Our team’s early work revolutionized cancer diagnostics and helped to develop an industry with over 350 cyclotrons, over 3,000 PET & PET/CT systems and 160 PET radiopharmaceutical distribution centers installed around the world today.  The same team has redefined cancer treatment, once again, with the introduction of the SC360 proton therapy system, on the market today.

View Team

Innovation Without Compromise

ProNova leverages superconducting magnet technology in both the cyclotron and gantry to dramatically reduce the size, weight and power, without sacrificing today’s most important clinical capabilities.  The SC360 seamlessly integrates with all OIS and TPS Solutions and provides the precision of proton therapy at dramatically lower costs.

Increased Precision

Integrated CBCT
In-beam PET at isocenter*
SMART Pencil Beam Scanning
Tumor Motion Tracking

*work in progress

Improved Productivity

360˚ treatment angle
Fast hypofractionation
Multiple fields with one image
Therapist operated

Reduced Costs

Facility
Equipment
Operations
Throughput

Don’t treat tomorrow’s patients with yesterday’s proton therapy technology.

Our SIMPLE DESIGN is pre-assembled, factory tested and shipped standard freight, which streamlines installation and start-up time while reducing costs.
A 360° TREATMENT ANGLE allows patients to remain in one position during treatment sessions, similar to traditional radiation treatment. This capability reduces the need to re-position and re-image during treatment sessions, resulting in faster treatment, higher throughput and greater accuracy.
SMART PENCIL BEAM SCANNING allows for Fast Scanning IMPT with optional apertures for maximum clinical flexibility.
A TWO-ROOM SOLUTION is the optimal balance connection of one cyclotron to two gantries. One, two or three room solutions are available.
3D ANATOMICAL AND FUNCTIONAL IMAGING AT THE ISOCENTER provides for the most advanced Image Guided Proton Therapy (IGPT) capabilities. Standard with cone beam CT and optional PET.

The Need for Proton Therapy

With just 26 existing proton therapy centers in the United States, only 3.6% of cancer patients eligible for proton therapy will actually be able to receive it this year.

More than 1.7 million people will be diagnosed with cancer this year in the US, and of those cases, 340,000 will be eligible for proton therapy. However, with just 26 existing proton therapy centers and 79 treatment rooms in the US that can treat a mere 23,700 patients each year, 1,054 more treatment rooms are needed. The need is even greater around the world. Of the 14.1 million people diagnosed with cancer every year, 2.8 million are candidates for proton therapy.

Careers

ProNova is aggressively developing the next generation of this advanced cancer treatment by delivering a lower-cost, smaller, lighter, more energy efficient solution without sacrificing performance and improving upon existing capabilities. The fusion of state-of-the-art imaging, multi-axis precision positioning, superconducting magnet technology, and unprecedented closed loop treatment verification using Positron Emission Tomography brings ProNova customers clinical, operational, and financial benefits that will make major improvements in patient care, outcomes, and value.

330 Pellissippi Place,
Maryville, TN 37804, USA
(865) 862-4100

  • This field is for validation purposes and should be left unchanged.